More on "hook effects" in immunometric assays for prostate-specific antigen
Myrtle, J.F.
Clinical Chemistry 35(10): 2154-2155
1989
ISSN/ISBN: 0009-9147 PMID: 2477177 Document Number: 339126
Document emailed within 1 workday
Related Documents
Vaidya, H.C.; Wolf, B.A.; Garrett, N.; Catalona, W.J.; Clayman, R.V.; Nahm, M.H. 1988: Extremely high values of prostate-specific antigen in patients with adenocarcinoma of the prostate; demonstration of the "hook effect" Clinical Chemistry 34(10): 2175-2177Jung, K.; Stephan, C.; Lein, M.; Henke, W.; Schnorr, D.; Brux, B.; Schürenkämper, P.; Loening, S.A. 1996: Analytical performance and clinical validity of two free prostate-specific antigen assays compared Clinical Chemistry 42(7): 1026-1033
Stenman, U.H.; Leinonen, J.; Alfthan, H.; Rannikko, S.; Tuhkanen, K.; Alfthan, O. 1991: A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer Cancer Research 51(1): 222-226
Walsh, T.; Warner, L.; Macaluso, M.; Frezieres, R.; Snead, M.; Wraxall, B. 2012: Prostate-specific antigen as a biomarker of condom failure: comparison of three laboratory assays and self-reported condom use problems in a randomized trial of female condom performance Contraception 86(1): 55-61
Walsh, T.; Warner, L.; Macaluso, M.; Frezieres, R.; Snead, M.; Wraxall, B. 2012: Prostate-specific antigen as a biomarker of condom failure: comparison of three laboratory assays and self-reported condom use problems in a randomized trial of female condom performance Contraception 86(1): 55-61
Romppanen, J.; Haapalainen, T.; Punnonen, K.; Penttilä, I. 2002: Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer Anticancer Research 22(1a): 415-420
Nixon, R.G.; Lilly, J.D.; Liedtke, R.J.; Batjer, J.D. 1997: Variation of free and total prostate-specific antigen levels: the effect on the percent free/total prostate-specific antigen Archives of Pathology and Laboratory Medicine 121(4): 385-391
Purnell, D.M.; Heatfield, B.M.; Trump, B.F. 1984: Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen Cancer Research 44(1): 285-292
Bostwick, D.G. 1994: Prostate-specific antigen. Current role in diagnostic pathology of prostate cancer American Journal of Clinical Pathology 102(4 Suppl 1): S31-S37
Wang, W.; Mo, Z.-N. 2010: Advances in prostate-specific membrane antigen targeted therapies for prostate cancer Zhonghua Nan Ke Xue 16(6): 547-551
Fornara, P.; Sturm, W.; Fabricius, P.G.; Schmiedt, E. 1987: Clinical relevance of radioimmunologic determination of prostate specific antigen in prostate cancer Der Urologe. Ausg. a 26(3): 158-161
Obralic, N.; Kulovac, B.; Aganovic, D.; Junuzovic, D. 2009: Values of prostate specific antigen in patients with operable prostate carcinoma Medicinski Arhiv 63(1): 34-37
Semjonow, A.; Hertle, L. 1995: Can the tumor stage of prostate carcinoma be determined with the aid of prostate-specific antigen? Der Urologe. Ausg. a 34(4): 290-296
Lieberman, S. 1999: Can percent free prostate-specific antigen reduce the need for prostate biopsy? Effective Clinical Practice: Ecp 2(6): 266-271
Schäfer, U.; Micke, O.; Hampel, G.; Brandt, B.; Bovenschulte, A.; Semjonow, A.; Willich, N. 1997: The use of prostate-specific antigen (PSA) for the monitoring of radiation therapy in prostate cancer Anticancer Research 17(4b): 2983-2986
Kelly, W.K.; Slovin, S.; Scher, H.I. 1996: Clinical use of posttherapy prostate-specific antigen changes in advanced prostate cancer Seminars in Oncology 23(6 Suppl 14: 8-14
Amayo, A.; Obara, W. 2004: Serum prostate specific antigen levels in men with benign prostatic hyperplasia and cancer of prostate East African Medical Journal 81(1): 22-26
Serdar, M.A.; Oguz, O.; Olgun, A.; Seçkin, B.; Ilgan, S.; Hasimi, A.; Salih, M.; Peker, F.; Kutluay, T. 2002: Diagnostic approach to prostate cancer using total prostate specific antigen-based parameters together Annals of Clinical and Laboratory Science 32(1): 22-30
Maeda, H.; Arai, Y.; Ishitoya, S.; Okubo, K.; Aoki, Y.; Okada, T.; Maekawa, S. 1998: Free-to-total prostate specific antigen ratio in clinical staging of prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 44(5): 307-311
Hardeman, S.W.; Wake, R.W.; Soloway, M.S. 1989: Two new techniques for evaluating prostate cancer. The role of prostate-specific antigen and transrectal ultrasound Postgraduate Medicine 86(2): 197-8 201 204 Passim